Key facts
- It has raised $115.0M; the latest was Later Stage VC ($50.0M) in Mar 2026.
- Notable investors include Earlybird Venture Capital, Wellington Partners, Longitude Capital, IDO Investments, DC Global Ventures — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Polares Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Polares Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Polares Medical
Developer of a medical device designed to treat patients suffering from mitral regurgitation. The company's device uses a unique trans-catheter mitral valve system to replace the posterior leaflet with a prosthetic leaflet, enabling physicians to make hemi-replacements of the mitral valve to enhance coaptation with the native anterior leaflet.
- Sector
- Healthcare
- HQ
- Palo Alto, CA, United States
- Founded
- 2017
- Employees
- 21
- Website
- polaresmedical.com/
- Ownership
- Privately Held (backing)
Polares Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Polares Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Polares Medical in its N-PORT filings yet. We sweep new filings monthly.